DPC Receives FDA Clearance to Market IMMULITE
DPC Receives FDA Clearance to Market IMMULITE® 2000 Allergen-Specific IgE as Third-Generation Assay Diagnostic Products Corporation (DPC) has been granted FDA 510(k) clearance to market IMMULITE® 2000 Allergen-Specific IgE as a third-generation as
Read More